Plutavimab | Interleukin Related interleukin-related.com

Product Name :
Plutavimab

Search keywords :
Plutavimab

drugId :
null

Target Vo:
Coronavirus spike glycoprotein

Target Vo Short Name :
S glycoprotein

Moa_Name:
Coronavirus spike glycoprotein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sorrento Therapeutics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Coronavirus Disease 2019 (COVID-19)

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Mouse CD28 Antibody (37.51) custom synthesis
Sacituzumab Epigenetics
M-CSF Antibody: M-CSF Antibody is a non-conjugated and Rabbit origined monoclonal antibody, targeting to M-CSF. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts